Antioxidants in the Processes of Retarding Ageing
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 24 January 2025 | Viewed by 4967
Special Issue Editors
Interests: aging; antioxidants; cell cycle regulation; cell death; longevity; yeast biology
Special Issues, Collections and Topics in MDPI journals
Interests: biomarkers; inflammation; oxidative stress; molecular biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Aging is defined as progressive physiological changes in an organism that lead to senescence, or a decline in biological functions and in the organism’s ability to adapt to metabolic stress. Numerous hypotheses exist to explain the organismal, cellular, and molecular mechanisms that underlie aging. A recent study indicates that aging is caused by an accumulation of molecular damage, e.g., from reactive oxygen species. Thus, it becomes increasingly important to find compounds that have antioxidant properties to slow down the aging process. In this issue, we invite manuscripts examining the biochemical and molecular mechanisms of action of antioxidants on aging based on model organisms and human cell lines as a crucial biological resource. Studies based on yeast, fruit flies, worms, mice, and rats are welcome. Focused original research articles and review paper are both welcome.
Dr. Mateusz Mołoń
Dr. Sabina Galiniak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- aging
- anti-aging medicine
- antioxidant
- model organisms
- oxidative stress markers
- reactive oxygen species
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.